ask="0.5443"
ask_size="5000"
average_daily_volume="2017500"
bid="0.5422"
bid_size="1000"
book_value="0.1800"
change="+0.0207"
change_from_200_day_moving_average="-1.7870"
change_from_50_day_moving_average="-0.5170"
change_from_52_week_high="-4.3579"
change_From_52_week_low="0.0321"
change_in_percent="+3.9701%"
close="0.5421"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.4440"
ebitda="-49.68M"
eps_estimate_current_year="-1.5900"
eps_estimate_next_quarter="-0.3300"
eps_estimate_next_year="-1.2900"
ex_dividend_date="N/A"
float_shares="36811000"
high="0.5440"
high_52_weeks="4.9000"
last_trade_date="1/31/2017"
last_trade_price="0.5421"
last_trade_size="12633"
last_trade_time="4:00pm"
low="0.5100"
low_52_weeks="0.5100"
market_capitalization="22.74M"
moving_average_200_day="2.3291"
moving_average_50_day="1.0591"
name="Anthera Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="2.8500"
open="0.5346"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-76.7244%"
percent_change_from_50_day_moving_average="-48.8145%"
percent_change_from_52_week_high="-88.9367%"
percent_change_from_52_week_low="+6.2941%"
previous_close="0.5214"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.8967"
price_per_sales="10.6037"
revenue="2.06M"
shares_outstanding="41955000"
short_ratio="1.8300"
stock_exchange="NGM"
symbol="ANTH"
volume="658488"
weeks_range_52="0.5100 - 4.9000"
